Phathom Pharmaceuticals target price cut to $16 from $20
PHAT•Jefferies cut its target price for Phathom Pharmaceuticals to $16 from $20.
Related News
Adobe: HSBC cuts to hold from buy, lowers target price to $267 from $310
ADBE•
FPL restores power to over 95% of customers affected by Isaias
NEE•
Citigroup target price cut to $135 from $150 by RBC
C•
Primerica survey shows BNPL use among middle-income Americans rises to 44% from 28% in Sept 2025
PRI•
Oil prices climb as traders weigh Saudi supply risk, Russian diesel flow
USO•